Prostaglandin E2 EP3 receptor regulates cyclooxygenase-2 expression in the kidney

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 3, 2012, Pages

  Vio, Carlos P ^a   Quiroz Munoz, Mariana ^a   Cuevas, Catherina A ^a   Cespedes, Carlos ^a   Ferreri, Nicholas R ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

COX 2; Coxibs; EP3 antagonist; Sulprostone; TAL

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; L 798106; MESSENGER RNA; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; ROFECOXIB; SULPROSTONE; UNCLASSIFIED DRUG; CYCLOOXYGENASE 2 INHIBITOR; DRUG DERIVATIVE; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E2; RNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; MORPHOMETRICS; NEGATIVE FEEDBACK; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; ENZYMOLOGY; FEEDBACK SYSTEM; GENETICS; KIDNEY CORTEX; KIDNEY TUBULE; METABOLISM; NEPHRON; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; BLOTTING, WESTERN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY CORTEX; KIDNEY TUBULES; MALE; NEPHRONS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE; RNA;

EID: 84864774602     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00634.2011     Document Type: Article

References (55)

1. Aoki J, Katoh H, Yasui H, Yamaguchi Y, Nakamura K, Hasegawa H, Ichikawa A, Negishi M. Signal transduction pathway regulating prostaglandin EP3 receptor-induced neurite retraction: requirement for two different tyrosine kinases. Biochem J 340: 365-369, 1999.
2. Audoly LP, Ma L, Feoktistov I, de Foe SK, Breyer MD, Breyer RM. Prostaglandin E-prostanoid-3 receptor activation of cyclic AMP response element-mediated gene transcription. J Pharmacol Exp Ther 289: 140148, 1999.
3. Bassil AK, Borman RA, Jarvie EM, McArthur-Wilson RJ, Thangiah R, Sung EZ, Lee K, Sanger GJ. Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon. Br J Pharmacol 154: 126-135, 2008.
4. +-2Cl~ cotransporter (NKCC2) in the thick ascending limb. Am J Physiol Renal Physiol 301: F94-F100, 2011.
5. Blewett N, Coller J, Goldstrohm A. A quantitative assay for measuring mRNA decapping by splinted ligation reverse transcription polymerase chain reaction: qSL-RT-PCR. RNA 17: 535-543, 2011.
6. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41: 661-690, 2001.
7. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25: 169-193, 2000.
8. Cheng HF, Wang JL, Zhang MZ, Miyazaki Y, Ichikawa I, McKanna JA, Harris RC. Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. J Clin Invest 103: 953-961, 1999.
9. Collino F, Bussolati B, Gerbaudo E, Marozio L, Pelissetto S, Benedetto C, Camussi G. Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol 294: F1185-F1194, 2008.
10. Eliopoulos AG, Dumitru CD, Wang CC, Cho J, Tsichlis PN. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J 21: 4831-4840, 2002.
11. Feng C, Beller EM, Bagga S, Boyce JA. Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses. Blood 107: 3243-3250, 2006.
12. Fernandez-Llama P, Ecelbarger CA, Ware JA, Andrews P, Lee AJ, Turner R, Nielsen S, Knepper MA. Cyclooxygenase inhibitors increase Na-K-2Cl cotransporter abundance in thick ascending limb of Henle's loop. Am J Physiol Renal Physiol 277: F219-F226, 1999.
13. Ferraris JD, Persaud P, Williams CK, Chen Y, Burg MB. cAMP-independent role of PKA in tonicity-induced transactivation of tonicity-responsive enhancer/ osmotic response element-binding protein. Proc Natl Acad Sci USA 99: 16800-16805, 2002.
14. Ferreri NR, An SJ, McGiff JC. Cyclooxygenase-2 expression and function in the medullary thick ascending limb. Am J Physiol Renal Physiol 277: F360-F368, 1999.
15. Ferreri NR, McGiff JC, Vio CP, Carroll MA. TNFalpha regulates renal COX-2 in the rat thick ascending limb (TAL). Thromb Res 110: 277-280, 2003.
16. Gately S, Li WW. Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Semin Oncol 31: 2-11, 2004.
17. Gonzalez AA, Cespedes C, Villanueva S, Michea L, Vio CP. E prostanoid-1 receptor regulates renal medullary alphaENaC in rats infused with angiotensin II. Biochem Biophys Res Commun 389: 372-377, 2009.
18. Hao CM, Breyer MD. Physiological regulation of prostaglandins in the kidney. Annu Rev Physiol 70: 357-377, 2008.
19. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 94: 2504-2510, 1994.
20. Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta 1299: 125-140, 1996.
21. Hocherl K, Kammerl MC, Schumacher K, Endemann D, Grobecker HF, Kurtz A. Role of prostanoids in regulation of the renin-angiotensin-aldosterone system by salt intake. Am J Physiol Renal Physiol 283: F294-F301, 2002.
22. Huling JC, Pisitkun T, Song JH, Yu MJ, Hoffert JD, Knepper MA. Gene expression databases for kidney epithelial cells. Am J Physiol Renal Physiol 302: F401-F407, 2012.
23. Inoue H, Tanabe T, Umesono K. Feedback control of cyclooxygenase-2 expression through PPARgamma. J Biol Chem 275: 28028-28032, 2000.
24. Jaimes EA, Tian RX, Pearse D, Raij L. Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. Kidney Int 68: 2143-2153, 2005.
25. Jensen BL, Stubbe J, Madsen K, Nielsen FT, Skott O. The reninangiotensin system in kidney development: role of COX-2 and adrenal steroids. Acta Physiol Scand 181: 549-559, 2004.
26. Jones RL, Giembycz MA, Woodward DF. Prostanoid receptor antagonists: development strategies and therapeutic applications. Br J Pharmacol 158: 104-145, 2009.
27. Kammerl MC, Nusing RM, Richthammer W, Kramer BK, Kurtz A. Inhibition of COX-2 counteracts the effects of diuretics in rats. Kidney Int 60: 1684-1691, 2001.
28. Kammerl MC, Nusing RM, Schweda F, Endemann D, Stubanus M, Kees F, Lackner KJ, Fischereder M, Kramer BK. Low sodium and furosemide-induced stimulation of the renin system in man is mediated by cyclooxygenase 2. Clin Pharmacol Ther 70: 468-474, 2001.
29. Kammerl MC, Nusing RM, Seyberth HW, Riegger GA, Kurtz A, Kramer BK. Inhibition of cyclooxygenase-2 attenuates urinary prosta-noid excretion without affecting renal renin expression. Pflügers Arch 442: 842-847, 2001.
30. Kammerl MC, Richthammer W, Kurtz A, Kramer BK. Angiotensin II feedback is a regulator of renocortical renin, COX-2, and nNOS expression. Am J Physiol Regul Integr Comp Physiol 282: R1613-R1617, 2002.
31. Kunikata T, Yamane H, Segi E, Matsuoka T, Sugimoto Y, Tanaka S, Tanaka H, Nagai H, Ichikawa A, Narumiya S. Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat Immunol 6: 524-531, 2005.
32. Leon CG, Marchetti J, Vio CP. Renal cyclooxygenase-2: evidence for recruitment of thick ascending limb of Henle cells in microdissected nephron segments. Hypertension 38: 630-634, 2001.
33. Madeddu P, Vio CP, Straino S, Salis MB, Milia AF, Emanueli C. Renal phenotype of low kallikrein rats. Kidney Int 59: 2233-2242, 2001.
34. Madsen K, Stubbe J, Yang T, Skott O, Bachmann S, Jensen BL. Low endogenous glucocorticoid allows induction of kidney cortical cyclooxy-genase-2 during postnatal rat development. Am J Physiol Renal Physiol 286: F26-F37, 2004.
35. Martin M, Meyer-Kirchrath J, Kaber G, Jacoby C, Flogel U, Schrader J, Ruther U, Schror K, Hohlfeld T. Cardiospecific overex-pression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury. Circulation 112: 400-406, 2005.
36. Matzdorf C, Kurtz A, Hocherl K. COX-2 activity determines the level of renin expression but is dispensable for acute upregulation of renin expression in rat kidneys. Am J Physiol Renal Physiol 292: F1782-F1790, 2007.
37. Meyer-Kirchrath J, Martin M, Schooss C, Jacoby C, Flogel U, Mar-zoll A, Fischer JW, Schrader J, Schror K, Hohlfeld T. Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart. Cardiovasc Res 81: 310-318, 2009.
38. Nasrallah R, Laneuville O, Ferguson S, Hebert RL. Effect of COX-2 inhibitor NS-398 on expression of PGE2 receptor subtypes in M-1 mouse CCD cells. Am J Physiol Renal Physiol 281: F123-F132, 2001.
39. Ristimaki A, Narko K, Hla T. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J 318: 325-331, 1996.
40. Rodriguez JA, Vio CP, Pedraza P, McGiff JC, Ferreri NR. Bradykinin regulates cyclooxygenase-2 in rat renal thick ascending limb cells. Hypertension 44: 230-235, 2004.
41. Roos-van Groningen MC, Eikmans M, Baelde HJ, de Heer E, Bruijn JA. Improvement of extraction and processing of RNA from renal biopsies. Kidney Int 65: 97-105, 2004.
42. Schlondorff D. Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int 44: 643-653, 1993.
43. Schwartz JI, Vandormael K, Malice MP, Kalyani RN, Lasseter KC, Holmes GB, Gertz BJ, Gottesdiener KM, Laurenzi M, Redfern KJ, Brune K. Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther 72: 50-61, 2002.
44. Sirois J, Levy LO, Simmons DL, Richards JS. Characterization and hormonal regulation of the promoter of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Identification of functional and protein-binding regions. J Biol Chem 268: 12199-12206, 1993.
45. Steinert D, Kuper C, Bartels H, Beck FX, Neuhofer W. PGE2 potentiates tonicity-induced COX-2 expression in renal medullary cells in a positive feedback loop involving EP2-cAMP-PKA signaling. Am J Physiol Cell Physiol 296: C75-C87, 2009.
46. Sugimoto Y, Narumiya S. Prostaglandin E receptors. J Biol Chem 282: 11613-11617, 2007.
47. Vial D, Arbibe L, Havet N, Dumarey C, Vargaftig B, Touqui L. Down-regulation by prostaglandins of type-II phospholipase A2 expression in guinea-pig alveolar macrophages: a possible involvement of cAMP. Biochem J 330: 89-94, 1998.
48. Villanueva S, Cespedes C, Gonzalez AA, Vio CP, Velarde V. Effect of ischemic acute renal damage on the expression of COX-2 and oxidative stress-related elements in rat kidney. Am J Physiol Renal Physiol 292: F1364-F1371, 2007.
49. Vio CP, An S, Cespedes C, McGiff JC, Ferreri NR. Induction of cyclooxygenase-2 in thick ascending limb cells by adrenalectomy. J Am Soc Nephrol 12: 649-658, 2001.
50. Vio CP, Balestrini C, Recabarren M, Cespedes C. Postnatal development of cyclooxygenase-2 in the rat kidney. Immunopharmacology 44: 205-210, 1999.
51. Vio CP, Cespedes C, Gallardo P, Masferrer JL. Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells. Hypertension 30: 687-692, 1997.
52. Whelton A, Schulman G, Wallemark C, Drower EJ, Isakson PC, Verburg KM, Geis GS. Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med 160: 1465-1470, 2000.
53. Woodward DF, Jones RL, Narumiya S. International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol Rev 63: 471-538, 2011.
54. Yang T, Singh I, Pham H, Sun D, Smart A, Schnermann JB, Briggs JP. Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Physiol Renal Physiol 274: F481-F489, 1998.
55. Zhang MZ, Yao B, Cheng HF, Wang SW, Inagami T, Harris RC. Renal cortical cyclooxygenase 2 expression is differentially regulated by angiotensin II AT1 and AT2 receptors. Proc Natl Acad Sci USA 103: 16045-16050, 2006.